| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Aug―13 |
Creatine Kinase and CK-MBin COVID-19: Clinical Significanceand Prognostic Value |
Piotr Łojko, Aldona Wierzbicka-Rucińska |
| 2 |
[GO] |
2026―Jun―15 |
Clinical Utility of Interleukin-6 for RiskStratification in Hospitalized COVID-19Patients: A Systematic Review andMeta-Analysis of Adjusted Estimates |
Piotr Łojko, Aldona Wierzbicka-Rucińska |
| 3 |
[GO] |
2025―Sep―26 |
Usefulness of routine molecular tests to assess theprevalence of SARS-CoV-2 variants |
Edyta Wesołowska, Ewa Miłosz, Zuzanna Sienkiewicz, Krzysztof Lewandowski |
| 4 |
[GO] |
2025―Jul―07 |
The significance of laboratory diagnostics in the monitoringof COVID-19 patients |
Ewelina Tobiczyk, Ewa Wysocka, Szymon Skoczyński, Szczepan Cofta |
| 5 |
[GO] |
2025―Feb―14 |
The use of NGS sequencing in Illumina technology as a method for examining the genetic variability of the SARS-CoV-2 virus |
Elżbieta Bartkowiak, Beata Rozwadowska, Marta Albertyńska, Adrian Miara, Grzegorz Hudzik |
